Gadoterate Meglumine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Gadoterate Meglumine Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status To Be Discontinued. The shortage was first posted on May 21, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Package NDC
- 65219-086-20
- Dosage Form
- Injection
- Presentation
- Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20)
- Initial Posting
- May 21, 2026